Picture of Gentian Diagnostics ASA logo

GENT Gentian Diagnostics ASA News Story

0.000.00%
no flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapFalling Star

Brief: Gentian Diagnostics Proposes Dividend Of NOK 0.40 Per Share

Feb 12 (Reuters) - Gentian Diagnostics ASA  GENT.OL :
    * Q4  SALES OF NOK 42.6 MILLION
    * Q4 IMPROVEMENT OF GROSS MARGIN TO 56%
    * Q4 EBITDA IMPROVEMENT TO NOK 8.1 MILLION IN 4Q24 VERSUS
NOK -1.0
 MILLION IN 4Q23
    * Q4 NET PROFIT OF NOK 45.3 MILLION
    * BOARD PROPOSES A DIVIDEND OF NOK 0.40 PER SHAR
    * TARGETS A MARKET SHARE OF 15- 20% FOR ITS PRODUCT
PORTFOLIO
    * EXPECTS REVENUE TAKE WILL VARY ACROSS PRODUCTS BUT REMAIN
WITHIN
30-50% RANGE FOR PRODUCT PORTFOLIO AS A WHOLE

Source text:  ID:nObiT98bba 
Further company coverage:  GENT.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Gentian Diagnostics ASA

See all news